DexCom Operating Income from 2010 to 2026
| DC4 Stock | EUR 61.93 0.59 0.96% |
Operating Income | First Reported 2016-12-31 | Previous Quarter 242.5 M | Current Value 323 M | Quarterly Volatility 95.7 M |
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 31.7 M, Selling General Administrative of 742.9 M or Total Revenue of 4.9 B, as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
DexCom | Operating Income |
The Operating Income trend for DexCom Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether DexCom is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest DexCom's Operating Income Growth Pattern
Below is the plot of the Operating Income of DexCom Inc over the last few years. Operating Income is the amount of profit realized from DexCom Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of DexCom Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. DexCom's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
DexCom Operating Income Regression Statistics
| Arithmetic Mean | 220,287,647 | |
| Coefficient Of Variation | 161.19 | |
| Mean Deviation | 291,926,644 | |
| Median | (20,600,000) | |
| Standard Deviation | 355,073,629 | |
| Sample Variance | 126077.3T | |
| Range | 1.1B | |
| R-Value | 0.86 | |
| Mean Square Error | 35513.1T | |
| R-Squared | 0.74 | |
| Significance | 0.000011 | |
| Slope | 60,320,637 | |
| Total Sum of Squares | 2017236.5T |
DexCom Operating Income History
About DexCom Financial Statements
DexCom stakeholders use historical fundamental indicators, such as DexCom's Operating Income, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | 911.8 M | 957.4 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of DexCom Correlation against competitors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.